Association of arterial events with the coexistence of metabolic syndrome and primary antiphospholipid syndrome
Contribuinte(s) |
UNIVERSIDADE DE SÃO PAULO |
---|---|
Data(s) |
01/10/2013
01/10/2013
2012
|
Resumo |
Objective Metabolic syndrome (MetS) is highly prevalent in rheumatic diseases and is recognized as a new independent cardiovascular risk factor. This study was undertaken to determine the clinical significance of MetS in patients with primary antiphospholipid syndrome (APS). Methods Seventy-one primary APS patients and 73 age- and sex-matched healthy controls were included. Serum samples were tested for lipid profile, Lp(a), glucose, insulin, thyroid-stimulating hormone, free T4, erythrocyte sedimentation rate, C-reactive protein level, and uric acid. MetS was defined by the International Diabetes Federation criteria, and insulin resistance was established using the homeostasis model assessment index. Results The prevalence of MetS was 33.8%, and further comparison between primary APS patients with and without MetS revealed that the former had a higher frequency of arterial events (79.2% versus 42.6%; P = 0.003), angina (29.2% versus 2.1%; P = 0.002), and positive lupus anticoagulant antibody (95.8% versus 76.6%; P = 0.049). In addition, primary APS patients with MetS, as expected, had a higher prevalence of cardiovascular risk factors. On multivariate analysis, only MetS was independently associated with arterial events in primary APS. Conclusion Coexistence of primary APS and MetS seems to identify a subgroup of patients with higher risk of arterial events, suggesting that MetS may aggravate existing endothelial abnormalities of primary APS. Federico Foundation Federico Foundation [2009/14784-8] Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [301411/2009-3, 300665/2009-1] |
Identificador |
ARTHRITIS CARE & RESEARCH, HOBOKEN, v. 64, n. 10, pp. 1576-1583, OCT, 2012 2151-464X http://www.producao.usp.br/handle/BDPI/33875 10.1002/acr.21701 |
Idioma(s) |
eng |
Publicador |
WILEY-BLACKWELL HOBOKEN |
Relação |
ARTHRITIS CARE & RESEARCH |
Direitos |
closedAccess Copyright WILEY-BLACKWELL |
Palavras-Chave | #SYSTEMIC-LUPUS-ERYTHEMATOSUS #DENSITY LIPOPROTEIN CHOLESTEROL #CORONARY-HEART-DISEASE #RISK-FACTORS #INSULIN-RESISTANCE #ACCELERATED ATHEROSCLEROSIS #CARDIOVASCULAR-DISEASE #CONSENSUS STATEMENT #ANTIBODIES #THROMBOSIS #RHEUMATOLOGY |
Tipo |
article original article publishedVersion |